Hims offers convenient and affordable access to treatments and products tailored for men's health needs. But how much does it ...

Hims & Hers Health (HIMS) stock gained after Citi upgraded the company, while agilon health (AGL) stock slipped after its downgrade. Read more here.

Deutsche Bank Aktiengesellschaft boosted their price target on Hims & Hers Health from $23.00 to $27.00 and gave the company a “hold” rating in a research note on Wednesday, November 6th.

NYSE:HIMS opened at $26.82 on Monday. The stock has a market cap of $5.86 billion, a price-to-earnings ratio of 60.96 and a beta of 1.31. The company’s 50 day moving average price is $26.73 and ...

OpenAI CEO Sam Altman and Meta both announced $1 million donations, and Amazon and Apple CEO Tim Cook have also reportedly ...

In recent trading, shares of Hims & Hers Health Inc (Symbol: HIMS) have crossed above the average analyst 12-month target price of $25.36, changing hands for $26.63/share. When a stock reaches the ...

Piper Sandler raised the firm’s price target on Hims & Hers to $24 from $21 and keeps a Neutral rating on the shares. Heading into the new year, the firm is watching the impact of rates and ...

Hims has become a leader in the weight loss treatment industry by offering access to men’s health solutions that are both ...

Hims & Hers said it would work with the incoming administration and share the company's point of view about the value of the medications.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Hims & Hers (NYSE:HIMS) has donated $1 million to President-elect Donald Trump's inaugural committee. The telehealth brand ...

Aarti Drugs Ltd share price was down by -2.78% from the previous closing price of ₹442.25. Who are peers of Aarti Drugs Ltd? The peers of Aarti Drugs Ltd are Sun Pharmaceuticals Industries Ltd ...